Rare disease drug development: challenges, support and hopes for the future

In the BioTechniques interview, Oxana Iliach, Senior Director of Regulatory Strategy at Certara, provides insights into the challenges and opportunities in rare disease drug development. She emphasizes the role of biosimulation in enhancing clinical trials, regulatory hurdles, and the importance of global collaboration. The interview highlights the critical contributions of organizations like the International Rare Disease Research Consortium (IRDiRC) in addressing challenges and creating synergy across various jurisdictions to accelerate progress in the rare disease landscape.